| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18823558 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Eustace AJ, Crown J, Clynes M, et al.
Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines. [JOURNAL ARTICLE]
J Transl Med 2008 Sep 29; 6(1):53.
Abstract | Full Citation | Find Related Articles | | Johnson FM, Saigal B, Talpaz M, et al.
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. [Journal Article]
Clin Cancer Res 2005 Oct 1; 11(19 Pt 1):6924-32.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tsao AS, He D, Saigal B, et al.
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion. [Journal Article]
Mol Cancer Ther 2007 Jul; 6(7):1962-72.
Abstract | Full Citation | | Shor AC, Keschman EA, Lee FY, et al.
Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. [Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't]
Cancer Res 2007 Mar 15; 67(6):2800-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Serrels A, Macpherson IR, Evans TR, et al.
Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib. [Journal Article]
Mol Cancer Ther 2006 Dec; 5(12):3014-22.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nam S, Kim D, Cheng JQ, et al.
Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. [Journal Article]
Cancer Res 2005 Oct 15; 65(20):9185-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chang Q, Jorgensen C, Pawson T, et al.
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. [JOURNAL ARTICLE]
Br J Cancer 2008 Sep 16.
Abstract | Full Citation | Find Related Articles | | Johnson FM, Saigal B, Tran H, et al.
Abrogation of Signal Transducer and Activator of Transcription 3 Reactivation after Src Kinase Inhibition Results in Synergistic Antitumor Effects. [JOURNAL ARTICLE]
Clin Cancer Res 2007 Jul 15; 13(14):4233-4244.
Abstract | Full Citation | Find Related Articles | | Guo T, Agaram NP, Wong GC, et al.
Sorafenib Inhibits the Imatinib-Resistant KITT670I Gatekeeper Mutation in Gastrointestinal Stromal Tumor. [Journal Article]
Clin Cancer Res 2007 Aug 15; 13(16):4874-81.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
